DNMT3A and leukemia: Studies have shown that DNMT3A mutation can prevent the differentiation of hematopoietic stem cells and leukemia cells via polycomb repressive complex 1 (37), and promote resistance to chemotherapy by interfering with the glutathione metabolism (19).